Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

Calcipotriol may effectively treat hair loss in alopecia areata, working better in children than adults.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Dupilumab helps children with alopecia areata regrow hair safely.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

The monkey's hair loss was due to an autoimmune disease, not genetics.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

People with Alopecia Areata have a higher risk of heart-related health issues.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Siddha therapeutics successfully treated a 14-year-old's alopecia areata, leading to full hair regrowth without side effects.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Azelaic acid cream can effectively treat scalp hair loss.

People with alopecia areata have much lower Vitamin-D levels than healthy individuals.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Children with alopecia areata often experience more anxiety and depression, linked to neglectful family dynamics.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.